Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 296

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

ESC Council on hypertension position document on the management of hypertensive emergencies

Open access
van den Born, Bert-Jan H, Lip, Gregory Y H, Brguljan-Hitij, Jana, Cremer, Antoine, Segura, Julian, Morales, Enrique, Mahfoud, Felix, Amraoui, Fouad, Persu, Alexandre, Kahan, Thomas, Agabiti Rosei, Enrico, de Simone, Giovanni, Gosse, Philippe, Williams, Bryan·2019·European Heart Journal - Cardiovascular Pharmacotherapy
DOI 10.1093/ehjcvp/pvy032
Open this paper in CoChat — free account

Abstract

Hypertensive emergencies are those situations where very high blood pressure (BP) values are associated with acute organ damage, and therefore, require immediate, but careful, BP reduction. The type of acute organ damage is the principal determinant of: (i) the drug of choice, (ii) the target BP, and (iii) the timeframe in which BP should be lowered. Key target organs are the heart, retina, brain, kidneys, and large arteries. Patients who lack acute hypertension-mediated end organ damage do not have a hypertensive emergency and can usually be treated with oral BP-lowering agents and usually discharged after a brief period of observation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ehjcvp/pvy032

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 78

  1. Vaughan, 2000, Hypertensive emergencies, Lancet, 356, 411, 10.1016/S0140-6736(00)02539-3 · DOI · Paper page
  2. Chester, 1978, Hypertensive encephalopathy: a clinicopathologic study of 20 cases, Neurology, 28, 928, 10.1212/WNL.28.9.928 · DOI · Paper page
  3. van den Born, 2007, The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension, Am J Hypertens, 20, 900, 10.1016/j.amjhyper.2007.02.018 · doi:10.1016/j.amjhyper.2007.02.018
  4. Amraoui, 2010, Value of retinal examination in hypertensive encephalopathy, J Hum Hypertens, 24, 274, 10.1038/jhh.2009.82 · doi:10.1038/jhh.2009.82
  5. Cremer, 2016, From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency, J Hum Hypertens, 30, 463, 10.1038/jhh.2015.112 · DOI
  6. Amraoui, 2014, Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study, J Clin Hypertens (Greenwich), 16, 122, 10.1111/jch.12243 · DOI · Paper page
  7. Hinchey, 1996, A reversible posterior leukoencephalopathy syndrome, N Engl J Med, 334, 494, 10.1056/NEJM199602223340803 · DOI · Paper page
  8. Patel, 2016, Characteristics and outcomes of patients presenting with hypertensive urgency in the office setting, JAMA Intern Med, 176, 981, 10.1001/jamainternmed.2016.1509 · DOI · Paper page
  9. Pinna, 2014, Hospital admissions for hypertensive crisis in the emergency departments: a large multicenter Italian study, PLoS One, 9, e93542., 10.1371/journal.pone.0093542 · DOI
  10. Zampaglione, 1996, Hypertensive urgencies and emergencies. Prevalence and clinical presentation, Hypertension, 27, 144, 10.1161/01.HYP.27.1.144 · DOI · Paper page
  11. Deshmukh, 2011, Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States, Am J Cardiol, 108, 1277, 10.1016/j.amjcard.2011.06.046 · DOI
  12. Martin, 2004, Hypertensive crisis profile. Prevalence and clinical presentation, Arq Bras Cardiol, 83, 131
  13. Janke, 2016, Trends in the incidence of hypertensive emergencies in US Emergency Departments from 2006 to 2013, J Am Heart Assoc, 5, e004511., 10.1161/JAHA.116.004511 · DOI
  14. Polgreen, 2015, Increasing trend in admissions for malignant hypertension and hypertensive encephalopathy in the United States, Hypertension, 65, 1002, 10.1161/HYPERTENSIONAHA.115.05241 · DOI
  15. Lip, 1994, The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England, J Hypertens, 12, 1297, 10.1097/00004872-199411000-00013 · DOI
  16. Marik, 2007, Hypertensive crises: challenges and management, Chest, 131, 1949, 10.1378/chest.06-2490 · DOI · Paper page
  17. van den Born, 2006, Ethnic disparities in the incidence, presentation and complications of malignant hypertension, J Hypertens, 24, 2299, 10.1097/01.hjh.0000249710.21146.38 · DOI · Paper page
  18. Cowley, 1979, Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs, Hypertension, 1, 549, 10.1161/01.HYP.1.6.549 · DOI
  19. Lohmeier, 1979, Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog, Circ Res, 44, 154, 10.1161/01.RES.44.2.154 · doi:10.1161/01.res.44.2.154
  20. Mohring, 1976, Effects of saline drinking on malignant course of renal hypertension in rats, Am J Physiol, 230, 849, 10.1152/ajplegacy.1976.230.3.849 · DOI
  21. Mohring, 1978, Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension, Circ Res, 42, 17, 10.1161/01.RES.42.1.17 · doi:10.1161/01.res.42.1.17
  22. Ahmed, 1986, Lack of difference between malignant and accelerated hypertension, Br Med J (Clin Res Ed), 292, 235, 10.1136/bmj.292.6515.235 · DOI
  23. McGregor, 1986, Retinal changes in malignant hypertension, Br Med J (Clin Res Ed), 292, 233, 10.1136/bmj.292.6515.233 · doi:10.1136/bmj.292.6515.233
  24. Lip, 2001, A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension, Am J Hypertens, 14, 823, 10.1016/S0895-7061(01)02045-3 · doi:10.1016/s0895-7061(01)02045-3
  25. van den Born, 2011, Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis, J Hypertens, 29, 922, 10.1097/HJH.0b013e328345023d · DOI
  26. van den Born, 2008, Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension, Hypertension, 51, 862, 10.1161/HYPERTENSIONAHA.107.103127 · doi:10.1161/hypertensionaha.107.103127
  27. Edvinsson, 1976, Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study, Brain Res, 115, 377, 10.1016/0006-8993(76)90356-5 · DOI · Paper page
  28. Katz, 2009, Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry, Am Heart J, 158, 599, 10.1016/j.ahj.2009.07.020 · DOI
  29. Grassi, 2008, Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles, J Clin Hypertens (Greenwich), 10, 662, 10.1111/j.1751-7176.2008.00001.x · DOI
  30. Neskovic, 2013, . Emergency echocardiography: the European Association of Cardiovascular Imaging recommendations, Eur Heart J Cardiovasc Imaging, 14, 1, 10.1093/ehjci/jes193 · DOI · Paper page
  31. Sforza, 2017, Diagnostic performance of multi-organ ultrasound with pocket-sized device in the management of acute dyspnea, Cardiovasc Ultrasound, 15, 16., 10.1186/s12947-017-0105-8 · doi:10.1186/s12947-017-0105-8
  32. Grossman, 1996, Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?, JAMA, 276, 1328, 10.1001/jama.1996.03540160050032 · DOI · Paper page
  33. Perez, 2008, Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review, J Hum Hypertens, 22, 596, 10.1038/jhh.2008.25 · DOI
  34. Ledingham, 1979, Cerebral complications in the treatment of accelerated hypertension, Q J Med, 48, 25, 10.1093/oxfordjournals.qjmed.a067564 · doi:10.1093/oxfordjournals.qjmed.a067564
  35. Haas, 1983, Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension, Am J Med, 75, 1071, 10.1016/0002-9343(83)90891-4 · doi:10.1016/0002-9343(83)90891-4
  36. Clifton, 1989, Intravenous nicardipine in severe systemic hypertension, Am J Cardiol, 64, 16H, 10.1016/0002-9149(89)90975-2 · doi:10.1016/0002-9149(89)90975-2
  37. Hirschl, 1997, Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies, Intensive Care Med, 23, 885, 10.1007/s001340050426 · doi:10.1007/s001340050426
  38. Wilson, 1983, Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies, Am J Med, 75, 95, 10.1016/0002-9343(83)90141-9 · doi:10.1016/0002-9343(83)90141-9
  39. Shusterman, 1993, Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function, Am J Med, 95, 161, 10.1016/0002-9343(93)90256-O · doi:10.1016/0002-9343(93)90256-o
  40. Pollack, 2009, Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension, Ann Emerg Med, 53, 329, 10.1016/j.annemergmed.2008.04.025 · doi:10.1016/j.annemergmed.2008.04.025
  41. Gosse, 2011, Impact of malignant arterial hypertension on the heart, J Hypertens, 29, 798, 10.1097/HJH.0b013e3283430b12 · DOI
  42. Immink, 2008, Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension, Hypertension, 52, 236, 10.1161/HYPERTENSIONAHA.108.110395 · doi:10.1161/hypertensionaha.108.110395
  43. Ahmed, 2000, Effect of intravenous nimodipine on blood pressure and outcome after acute stroke, Stroke, 31, 1250, 10.1161/01.STR.31.6.1250 · DOI · Paper page
  44. Sandset, 2011, The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial, Lancet, 377, 741, 10.1016/S0140-6736(11)60104-9 · DOI · Paper page
  45. Powers, 2018, Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 49, e46, 10.1161/STR.0000000000000158 · DOI · Paper page
  46. Jovin, 2015, Thrombectomy within 8 hours after symptom onset in ischemic stroke, N Engl J Med, 372, 2296, 10.1056/NEJMoa1503780 · DOI · Paper page
  47. Albers, 2018, Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging, N Engl J Med, 378, 708, 10.1056/NEJMoa1713973 · DOI · Paper page
  48. Nogueira, 2018, Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct, N Engl J Med, 378, 11, 10.1056/NEJMoa1706442 · DOI · Paper page
  49. Anderson, 2010, Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT), Stroke, 41, 307, 10.1161/STROKEAHA.109.561795 · DOI · Paper page
  50. Anderson, 2013, Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage, N Engl J Med, 368, 2355, 10.1056/NEJMoa1214609 · DOI · Paper page
  51. Qureshi, 2016, Intensive blood-pressure lowering in patients with acute cerebral hemorrhage, N Engl J Med, 375, 1033, 10.1056/NEJMoa1603460 · DOI · Paper page
  52. Roffi, 2016, 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J, 37, 267, 10.1093/eurheartj/ehv320 · DOI · Paper page
  53. Marx, 1979, Labetalol infusion in acute myocardial infarction with systemic hypertension, Br J Clin Pharmacol, 8, 233S, 10.1111/j.1365-2125.1979.tb04787.x · doi:10.1111/j.1365-2125.1979.tb04787.x
  54. Frishman, 1981, Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade, Am J Cardiol, 48, 917, 10.1016/0002-9149(81)90359-3 · DOI
  55. Chiariello, 1976, Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction, Circulation, 54, 766, 10.1161/01.CIR.54.5.766 · doi:10.1161/01.cir.54.5.766
  56. Mann, 1978, Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin, Circulation, 57, 732, 10.1161/01.CIR.57.4.732 · doi:10.1161/01.cir.57.4.732
  57. Durrer, 1982, Effect of sodium nitroprusside on mortality in acute myocardial infarction, N Engl J Med, 306, 1121, 10.1056/NEJM198205133061901 · DOI
  58. Gregorini, 1998, Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents, J Am Coll Cardiol, 31, 992, 10.1016/S0735-1097(98)00055-2 · DOI
  59. Gregorini, 1999, Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction, Circulation, 99, 482, 10.1161/01.CIR.99.4.482 · DOI
  60. Ponikowski, 2016, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 · DOI · Paper page
  61. Schreiber, 1998, The nitura study–effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema, Intensive Care Med, 24, 557, 10.1007/s001340050615 · doi:10.1007/s001340050615
  62. Ulici, 2017, Clevidipine versus sodium nitroprusside in acute aortic dissection: a retrospective chart review, Am J Emerg Med, 35, 1514, 10.1016/j.ajem.2017.06.030 · DOI
  63. Hiratzka, 2010, Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine, J Am Coll Cardiol, 55, e27, 10.1016/j.jacc.2010.02.015 · DOI · Paper page
  64. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy, 2013, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy, Obstet Gynecol, 122, 1122
  65. Duley, 2006, Drugs for treatment of very high blood pressure during pregnancy, Cochrane Database Syst Rev, CD001449
  66. Magee, 2003, Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis, BMJ, 327, 955, 10.1136/bmj.327.7421.955 · DOI · Paper page
  67. McCord, 2008, Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, Circulation, 117, 1897, 10.1161/CIRCULATIONAHA.107.188950 · DOI · Paper page
  68. Boehrer, 1993, Influence of labetalol on cocaine-induced coronary vasoconstriction in humans, Am J Med, 94, 608, 10.1016/0002-9343(93)90212-8 · DOI · Paper page
  69. Brogan, 1991, Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin, J Am Coll Cardiol, 18, 581, 10.1016/0735-1097(91)90617-I · DOI · Paper page
  70. Briggs, 1978, Hypertensive response to labetalol in phaeochromocytoma, Lancet, 1, 1045, 10.1016/S0140-6736(78)90772-9 · DOI
  71. Sheaves, 1995, The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma, Postgrad Med J, 71, 58, 10.1136/pgmj.71.831.58-a · doi:10.1136/pgmj.71.831.58-a
  72. Boutros, 1990, Perioperative management of 63 patients with pheochromocytoma, Cleve Clin J Med, 57, 613, 10.3949/ccjm.57.7.613 · DOI
  73. Tauzin-Fin, 2004, Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma, Br J Anaesth, 92, 512, 10.1093/bja/aeh083 · doi:10.1093/bja/aeh083
  74. Steingart, 2012, Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors, Am Heart J, 163, 156, 10.1016/j.ahj.2011.10.018 · DOI
  75. Lane, 2009, Improving survival of malignant hypertension patients over 40 years, Am J Hypertens, 22, 1199, 10.1038/ajh.2009.153 · DOI
  76. Gonzalez, 2010, Long-term renal survival in malignant hypertension, Nephrol Dial Transplant, 25, 3266, 10.1093/ndt/gfq143 · DOI · Paper page
  77. Amraoui, 2012, Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study, BMC Nephrol, 13, 71., 10.1186/1471-2369-13-71 · DOI
  78. Shantsila, 2017, Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry, J Hypertens, 35, 2310, 10.1097/HJH.0000000000001446 · DOI

Cited by

See all 296

Metadata

Authors
van den Born, B.-J. H., Lip, G. Y. H., Brguljan-Hitij, J., Cremer, A., Segura, J., Morales, E., Mahfoud, F., Amraoui, F., Persu, A., Kahan, T., Agabiti Rosei, E., de Simone, G., Gosse, P., & Williams, B.
Venue
European Heart Journal - Cardiovascular Pharmacotherapy
Publisher
Oxford University Press (OUP)
Published
2018-08-25
Volume
5
Issue
1
Pages
37-46
ISSN
  • 2055-6837 (ISSN-L)
  • 2055-6845
DOI
10.1093/ehjcvp/pvy032
OpenAlex
W2888027923
Cited by
296
References
2
FWCI
16.00
Type
journal article
Language
en
Open access
bronze
Licence
academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ESC Council on hypertension position document on the management of hypertensive emergencies. https://app.cochat.ai/papers/10.1093/ehjcvp/pvy032
The paper
van den Born, B.-J. H., Lip, G. Y. H., Brguljan-Hitij, J., Cremer, A., Segura, J., Morales, E., Mahfoud, F., Amraoui, F., Persu, A., Kahan, T., Agabiti Rosei, E., de Simone, G., Gosse, P., & Williams, B. (2019). ESC Council on hypertension position document on the management of hypertensive emergencies. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvy032

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.